These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 222512)
41. The effect of a high cholesterol and saturated fat diet on serum high-density lipoprotein-cholesterol, apoprotein A-I, and apoprotein E levels in normolipidemic humans. Tan MH; Dickinson MA; Albers JJ; Havel RJ; Cheung MC; Vigne JL Am J Clin Nutr; 1980 Dec; 33(12):2559-65. PubMed ID: 6776798 [TBL] [Abstract][Full Text] [Related]
42. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
43. Serum concentrations of lipids and apolipoproteins in normal and hyperemetic pregnancies. Ustün Y; Engin-Ustün Y; Dökmeci F; Söylemez F J Matern Fetal Neonatal Med; 2004 May; 15(5):287-90. PubMed ID: 15280117 [TBL] [Abstract][Full Text] [Related]
44. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man. Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553 [TBL] [Abstract][Full Text] [Related]
45. Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL. Shafrir E; Levy E; Deckelbaum R Nephron; 1990; 56(1):24-9. PubMed ID: 2234246 [TBL] [Abstract][Full Text] [Related]
46. Catabolism of very low density lipoproteins in experimental nephrosis. Garber DW; Gottlieb BA; Marsh JB; Sparks CE J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830 [TBL] [Abstract][Full Text] [Related]
47. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria. Saku K; Mendoza SG; Laver M; Hynd BA; Gartside PS; Kashyap ML Nephron; 1988; 50(2):112-5. PubMed ID: 3146703 [TBL] [Abstract][Full Text] [Related]
48. Sialic acid in childhood renal diseases: correlation with clinical and laboratory indices. Bircan Z; Batun S; Kervancioğlu M; Soran M; Kaplan A; Onur H; Demir F Acta Paediatr Jpn; 1998 Feb; 40(1):65-9. PubMed ID: 9583204 [TBL] [Abstract][Full Text] [Related]
49. Urine annexin A1 as an index for glomerular injury in patients. Ka SM; Tsai PY; Chao TK; Yang SM; Hung YJ; Chen JS; Shui HA; Chen A Dis Markers; 2014; 2014():854163. PubMed ID: 24591769 [TBL] [Abstract][Full Text] [Related]
50. Characterization of cationic albumin in minimal change nephropathy. Ghiggeri GM; Ginevri F; Candiano G; Oleggini R; Perfumo F; Queirolo C; Gusmano R Kidney Int; 1987 Oct; 32(4):547-53. PubMed ID: 3430951 [TBL] [Abstract][Full Text] [Related]
51. Serum and urinary lipoproteins in the human nephrotic syndrome: evidence for renal catabolism of lipoproteins. Shore VG; Forte T; Licht H; Lewis SB Metabolism; 1982 Mar; 31(3):258-68. PubMed ID: 6804750 [No Abstract] [Full Text] [Related]
52. Acute myocardial infarction in a young boy with nephrotic syndrome: a case report and review of the literature. Hopp L; Gilboa N; Kurland G; Weichler N; Orchard TJ Pediatr Nephrol; 1994 Jun; 8(3):290-4. PubMed ID: 7917853 [TBL] [Abstract][Full Text] [Related]
53. Lipoprotein profiles at different stages of the nephrotic syndrome. Querfeld U; Gnasso A; Haberbosch W; Augustin J; Schärer K Eur J Pediatr; 1988 Apr; 147(3):233-8. PubMed ID: 3391217 [TBL] [Abstract][Full Text] [Related]
54. Effect of methylprednisolone therapy on lipoprotein metabolism in human nephrotic syndrome. Kuzemková L; Stríbrná J; Kovár J; Poledne R; Matousovic K Int Urol Nephrol; 1989; 21(4):429-34. PubMed ID: 2613472 [TBL] [Abstract][Full Text] [Related]
55. [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases]. Olbricht CJ Klin Wochenschr; 1991 Aug; 69(11):455-62. PubMed ID: 1921228 [TBL] [Abstract][Full Text] [Related]
56. Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies. Lopes-Virella M; Virella G; Debeukelaer M; Owens CJ; Colwell JA Clin Chim Acta; 1979 May; 94(1):73-81. PubMed ID: 222512 [TBL] [Abstract][Full Text] [Related]
57. Urinary high density lipoprotein--a possible marker for glomerular proteinuria. Gomo Z Cent Afr J Med; 1991 Jul; 37(7):211-6. PubMed ID: 1811905 [TBL] [Abstract][Full Text] [Related]
58. High-density lipoprotein apolipoproteins in urine: I. Characterization in normal subjects and in patients with proteinuria. Gomo ZA; Henderson LO; Myrick JE Clin Chem; 1988 Sep; 34(9):1775-80. PubMed ID: 3138041 [TBL] [Abstract][Full Text] [Related]